e18877 Background: Being diagnosed with cancer and having to navigate what to do next is overwhelming. One of the initial actions that needs to be taken is choosing an oncologist. It is essential that each patient finds an oncologist they trust and who will work with them through their diagnosis and treatment. CVS Health conducted this study to gain insight into 1) how cancer patients select an oncologist and what factors weigh into choosing an oncologist and 2) treatment cost concerns. Methods: In August 2022, we conducted an online survey with consumers selected from a national online panel. Patients (n = 126) were included if they had cancer, employer health insurance and currently undergoing or having completed chemotherapy infusion, oral chemotherapy, hormone therapy or immunotherapy. Patients answered a series of questions designed to understand how they selected their oncologist. Descriptive statistics and percentages are reported. Results: Oncology diagnoses included breast (48%), colon or rectal (8%), leukemia (8%), melanoma (7%), basal cell (6%), ovarian (6%), endometrial (6%), testicular (6%), prostate (5%), lung (4%) and < 3% of other cancers (patients could choose multiple diagnoses). Most (79%) patients completed treatment; 75% received or were receiving chemotherapy infusion, 63% surgery, 60% radiation therapy, 29% hormone therapy and 22% oral chemotherapy. 68% of patients responded that someone suggested/referred them to their oncologist. Of these patients, 43% stated a specialist (other than an oncologist) referred them to their oncologist, 34% said their primary care physician (PCP) referred them, while hospital/treatment center, family member/friend, insurance company and other made up the rest. 38% of respondents received a second opinion. Most (89%) patients remained with the same oncologist throughout their treatment. When selecting an oncologist, most patients identified experience (93%), being a respected oncologist (90%), reputation (86%), being in network (77%), quality measures (74%) and treatment recommendations (73%) as “Very Important” factors when choosing an oncologist. 38% of patients began to worry about medical bills when diagnosed; however, 30% were never concerned. Over half (56%) of patients reported treatment cost as the most concerning bill. 82% of patients reached their deductible during treatment, with half (54%) expecting to hit their deductible less than 3 months into treatment. 75% of respondents reported hitting their out-of-pocket maximum; 39% hit it less than 3 months into treatment. Conclusions: Specialists and PCPs are integral in referring patients to oncologists. While patients are less likely to choose their oncologists directly, they report that experience, reputation, and quality of care are essential qualities in an oncologist. Cost was not an important factor when choosing an oncologist, however, patients are concerned with medical bills, specifically treatment costs.